Nuveen Asset Management, LLC Cidara Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

  • $329 Billion
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$1.87 - $2.7 $369,356 - $533,295
-197,517 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$2.06 - $3.01 $128,251 - $187,396
62,258 Added 46.03%
197,517 $526,000
Q4 2020

Feb 16, 2021
BUY
$1.99 - $3.25 $2,612 - $4,267
1,313 Added 0.98%
135,259 $270,000
Q3 2020

Nov 16, 2020
SELL
$2.85 - $4.1 $82,507 - $118,694
-28,950 Reduced 17.77%
133,946 $382,000
Q2 2020

Aug 14, 2020
BUY
$2.39 - $4.0 $389,321 - $651,584
162,896 New
162,896 $602,000

Others Institutions Holding CDTX

# of Institutions
52
Shares Held
22.1M
Call Options Held
2.7K
Put Options Held
100
View Full List

About Cidara Therapeutics, Inc.

CDTX Quotes by TradingView
  • Ticker CDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,075,696
  • Market Cap $889M
  • Description
  • Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...
More about CDTX
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email